Duality Advisers, LP Axsome Therapeutics, Inc. Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$30.7 - $43.36 $1.13 Million - $1.6 Million	-36,793 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$19.91 - $68.26 $732,548 - $2.51 Million	36,793 New	36,793 $1.21 Million
Q2 2021 Aug 09, 2021	SELL	$50.63 - $73.5 $850,280 - $1.23 Million	-16,794 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$55.91 - $81.44 $575,257 - $837,936	10,289 Added 158.17%	16,794 $951,000
Q4 2020 Feb 09, 2021	SELL	$66.31 - $86.52 $642,875 - $838,811	-9,695 Reduced 59.85%	6,505 $530,000
Q3 2020 Nov 12, 2020	BUY	$68.34 - $85.84 $1.11 Million - $1.39 Million	16,200 New	16,200 $1.15 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.